Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease
- PMID: 18588260
Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease
Comment on
-
Review article: the evidence base for interventions used to maintain remission in Crohn's disease.Aliment Pharmacol Ther. 2008 Jan 1;27(1):11-8. doi: 10.1111/j.1365-2036.2007.03536.x. Epub 2007 Oct 5. Aliment Pharmacol Ther. 2008. PMID: 17919275 Review.